NASDAQ
20.12.24
22:00 Uhr
7,700 US-Dollar
+0,250
+3,36 %
+3,36 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| LENSAR Aktie jetzt für 0€ handeln | |||||
| 09.12. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 17 | GlobeNewswire (Europe) | ORLANDO, Fla., Dec. 09, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted... ► Artikel lesen | |
| 26.11. | LENSAR, Inc.: LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day | 2 | GlobeNewswire (USA) | ||
| 07.11. | LENSAR, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.11. | LENSAR, Inc.: LENSAR Reports Third Quarter 2024 Results and Provides Business Update | 69 | GlobeNewswire (Europe) | 24 ALLY Robotic Laser Cataract Systems placed in 3Q 2024 including 11 sales in EU and Southeast Asia; Robust backlog with 24 systems pending installation as of September 30, 2024 38% Revenue... ► Artikel lesen | |
| 07.11. | LENSAR, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 01.11. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 109 | GlobeNewswire (Europe) | ORLANDO, Fla., Nov. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted... ► Artikel lesen | |
| 01.11. | LENSAR (LNSR) Set to Announce Earnings on Thursday | 1 | MarketBeat | ||
| 31.10. | LENSAR, Inc.: LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024 | 1 | GlobeNewswire (USA) | ||
| 14.10. | LENSAR Stock Soars to 52-Week High, Reaching $5.62 | 2 | Investing.com | ||
| 08.10. | LENSAR, Inc.: One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems | 1 | GlobeNewswire (USA) | ||
| 02.10. | LENSAR, Inc.: LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 80 | GlobeNewswire (Europe) | ORLANDO, Fla., Oct. 01, 2024 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or the "Company") today announced that a majority of the independent members of LENSAR's board of directors granted... ► Artikel lesen | |
| 29.08. | Lensar director Gary M. Winer buys $10,373 in company stock | 1 | Investing.com | ||
| 24.08. | LensAR director Gary M. Winer buys shares worth over $2,000 | 1 | Investing.com | ||
| 20.08. | Lensar director Gary Winer buys shares worth over $2,000 | 1 | Investing.com | ||
| 15.08. | Lensar director Gary M. Winer buys $6,215 in company stock | 1 | Investing.com | ||
| 08.08. | LENSAR reports Q2 results | 3 | Seeking Alpha | ||
| 08.08. | LENSAR, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.08. | LENSAR Reports Second Quarter 2024 Results and Provides Business Update | 122 | Business Wire | ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR®, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced laser solutions for the treatment of cataracts... ► Artikel lesen | |
| 07.08. | LENSAR, Inc.: LENSAR Announces Certification for the ALLY Adaptive Cataract Treatment System in the European Union | 303 | Business Wire | First EU ALLY Commercial Installation Planned for August 2024
LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced laser solutions for... ► Artikel lesen | |
| 09.05. | LENSAR Reports First Quarter 2024 Results and Provides Business Update | 223 | Business Wire | ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of... ► Artikel lesen |
Seite:
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| EMEIS | 5,162 | +1,04 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| NANO-X IMAGING | 6,770 | +3,04 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,075 | +3,71 % | Butterfly Network (NYSE:BFLY) Shares Down 6.3% - What's Next? | ||
| CARMAT | 0,960 | -0,52 % | Successful first "Aeson European User Meeting", marking an important step in the deployment of CARMAT's artificial heart | More than 100 healthcare professionals from 41 hospitals and 10 countries rallied to share their experiences of the Aeson® artificial heart All hospitals taking part in the event confirmed... ► Artikel lesen | |
| GOODRX | 4,450 | -0,89 % | GoodRx stock rises 5% after new CEO appointment | ||
| TALKSPACE | 2,985 | -0,83 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| JOINT CORP | 10,300 | +0,10 % | The Joint Corp. Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SCOTTSDALE, Ariz., Oct. 15, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) ("The Joint or "the Company"), the nation's largest franchisor of chiropractic care through The Joint Chiropractic®... ► Artikel lesen | |
| MIMEDX | 9,110 | +0,33 % | MiMedx Group, Inc: MIMEDX Files Patent Infringement Lawsuit Against Surgenex | ||
| PROCEPT BIOROBOTICS | 81,25 | +0,58 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,885 | -4,73 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| PROGYNY | 14,350 | +1,13 % | Progyny, Inc. Announces Third Quarter 2024 Results | Sales Season Yields Over 80 New Clients, 1.1 Million New Covered LivesSelected by a Leading National Health Plan and a Regional Health Plan as Their Preferred Partner1.5 Million Lives Adopt Newest... ► Artikel lesen | |
| BIOMERICA | 0,275 | +3,46 % | BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| ATRICURE | 30,725 | +2,25 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| PROPHASE LABS | 0,630 | -3,54 % | ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline |
LENSAR INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,250 (+3,36 %) liegt der Kurs bei 7,700 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LENSAR INC finden Sie auf Wallstreet Online.
